Related Experiment Video
Updated: Jul 3, 2026

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
What potential role is there for medication treatment in anorexia nervosa?
Scott J Crow1, James E Mitchell, James D Roerig
1Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minnesota 55454-1495, USA. crowx002@umn.edu
Objective:
To review selected issues regarding the development of drug treatments for anorexia nervosa (AN).
Method:
The existing pharmacotherapy literature for AN is reviewed, and the theoretical and practical considerations are discussed.
Results:
A very wide variety of drugs have been examined in AN, generally with negative results. There are a number of potential reasons for this finding, including compliance, nutritional deficits, selection of the wrong targets or the wrong outcome measures, use of monotherapy, lack of animal models, or factors intrinsic to AN.
Conclusion:
Pharmacotherapy provides little benefit in the treatment of AN at present. Several strategies might lead to the identification of more effective agents, including new measurement strategies, identification of novel pharmacologic targets, and consideration of a clinical trials network.
Related Concept Videos
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Bulimia Nervosa
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents
Binge Eating Disorders

